ESOPHAGEAL ADENOCARCINOMA

This study tested whether adding the targeted drug trastuzumab to standard chemoradiation helps people with HER2-positive esophageal cancer. About 200 adults with early-stage cancer took part. The goal was to see if the combination delays cancer return or improves survival.

This early-phase study tested a new drug called cabotamig in 33 adults with advanced gastrointestinal cancers (like colon, stomach, liver, or pancreatic cancer) that had stopped responding to standard treatments. The drug works by attaching to a marker on cancer cells and helping…

This study tested a combination of three drugs—regorafenib, nivolumab, and chemotherapy—in 30 people with advanced or recurrent stomach, gastroesophageal junction, or esophageal cancer that could not be removed by surgery. The goal was to see if the combination was safe and effec…

This early-stage study tested a new drug called SGN-B6A in 6 Chinese adults with advanced solid tumors (lung, head/neck, esophageal, or stomach cancers) that had stopped responding to standard treatments. The main goal was to check the drug's safety and side effects, and to see h…

This study tested a procedure called spray cryotherapy, which freezes tumors inside the esophagus, to quickly improve swallowing in 15 patients with advanced esophageal cancer. Participants received the freezing treatment during a routine scope exam, before starting chemotherapy …

This study compared two common procedures for treating Barrett's esophagus, a condition that can lead to esophageal cancer. Researchers wanted to see which treatment caused less pain and discomfort for patients. 62 adults took part, and the study measured pain right after the pro…

This study looked at whether having low oxygen levels after surgery to remove esophageal cancer increases the chance of a leak where the esophagus is reconnected. Researchers reviewed records from over 2000 patients and compared those with low oxygen to those with normal oxygen. …